RAC 0.93% $1.62 race oncology ltd

[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene, page-39

  1. 444 Posts.
    lightbulb Created with Sketch. 379
    DJ fair enough you don't rate the interview. I agree it's unlikely to drive any impact on the share price.

    However it's more likely to enhance new investor awareness, potential buying and potentially resultant share price appreciation - than not doing an interview.

    I'd also argue it doesn't consume much of Dr Tillet's time. The spiel he knows back to front now and it was 4 minutes in duration. Assuming they also have direct cost... I can't imagine it's endangering the trials budgets.

    Fine if you're just venting steam, I get tired of the mind numbing, eye watering carry on about selling investment properties etc sometimes, but is there something you consider to be a more constructive use of, that, lets say, hour of management team time?

    Last edited by EDTD: 11/05/24
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.62
Change
0.015(0.93%)
Mkt cap ! $276.0M
Open High Low Value Volume
$1.69 $1.69 $1.55 $456.4K 284.2K

Buyers (Bids)

No. Vol. Price($)
1 300 $1.59
 

Sellers (Offers)

Price($) Vol. No.
$1.62 2659 1
View Market Depth
Last trade - 16.10pm 30/07/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.